Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Racks Up 25th Partnership in Deal with Biosource

NEW YORK, Dec 18 – Luminex said Monday it has signed an agreement with immunoassay maker Biosource International to jointly develop assay and reagent kits using Luminex’s Labmap technology.

Under terms of the agreement, Luminex has received an advance on royalties from the sale of the assays. BioSource, Luminex's 25th partner, will begin marketing the new assay panels using the LabMap technologies beginning early next year.  

The LabMap technology uses microspheres, small lasers, digital processors, and software to perform up to 100 assays per drop of fluid. Biosource is planning to use this technology to develop assays that detect post-translational modification of proteins in order to understand the underlying mechanics of disease processes.   

Biosource will combine this with its signal transduction, cytokine, immunology, and neuroscience kits.

" BioSource's unique assay capabilities in the areas of cytokines, signal transduction and immunology, combined with our proprietary technology, will strengthen both companies' positions in the marketplace,” John Porter, Luminex's director of business development, said in a statement.



Luminex’ business strategy focuses on developing partnerships with outside companies to commercialize its technology. Bio-Rad, Hitachi, Qiagen, and Upstate Technology have also recently signed on as partners.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.